Efficacy of β-lactam/β-lactamase inhibitor combination is linked to WhiB4-mediated changes in redox physiology of Mycobacterium tuberculosis

MLA

Valakunja Nagaraja, et al. “Efficacy of β-Lactam/β-Lactamase Inhibitor Combination Is Linked to WhiB4-Mediated Changes in Redox Physiology of Mycobacterium Tuberculosis.” ELife, vol. 6, May 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6e80fdb08491f9963bc9f1a160f10399&authtype=sso&custid=ns315887.

APA

Valakunja Nagaraja, Rajiv Kumar Jha, Kushi Anand, Ashima Bhaskar, Priyanka Baloni, Amit Singh, Saurabh Mishra, Nagasuma Chandra, R. S. Rajmani, Prashant Shukla, & Abhilash Mohan. (2017). Efficacy of β-lactam/β-lactamase inhibitor combination is linked to WhiB4-mediated changes in redox physiology of Mycobacterium tuberculosis. ELife, 6.

Chicago

Valakunja Nagaraja, Rajiv Kumar Jha, Kushi Anand, Ashima Bhaskar, Priyanka Baloni, Amit Singh, Saurabh Mishra, et al. 2017. “Efficacy of β-Lactam/β-Lactamase Inhibitor Combination Is Linked to WhiB4-Mediated Changes in Redox Physiology of Mycobacterium Tuberculosis.” ELife 6 (May). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6e80fdb08491f9963bc9f1a160f10399&authtype=sso&custid=ns315887.